TransCode Therapeutics appoints Jack Stover to Board of Directors

Transcode Therapeutics, Inc.

Jack Stover appointed to Board effective Dec 19, 2025; joins Audit and Nominating Committees.
Dr. Magda Marquet resigns from Audit Committee following Stover's appointment.
Stover brings over 30 years life sciences leadership; currently Chairman of Traws Pharma (TRAW).
Previously CEO of Antares Pharma (ANTR), led sale to Halozyme for over $900 million.
Stover is designated as independent director and financial expert.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.